US EditionOzempic Patent End: What Changes for Millions of Patients
2 Articles
2 Articles
On March 20, 2026, the patent of the Ozempic expired, the medicine created as a treatment for type 2 diabetes, but which has been popularized by its use for weight loss.With this, the semaglutide, the active substance of the treatment that was created by the Danish pharmaceutical company Novo Nordisk, can be produced generically and will change the lives of millions of patients.But what does the end of the Ozempic patent and the beginning of its…
The Danish pharmaceutical company Novo Nordisk lost the exclusivity of semaglutide, the active substance of the medicines Ozempic and Wegovy, used to control diabetes and obesity, after overcoming the patent that legally protected it. This opens the door to the production and marketing of generic products, with more affordable prices, especially in countries with [...] The article Expires patent of the Ozempic; now it can be sold as a generic ap…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
